Reuters logo
5 months ago
BRIEF-Ignyta to explore strategic options for Taladegib through amendment of Taladegib license agreement with Lilly
March 23, 2017 / 8:48 PM / 5 months ago

BRIEF-Ignyta to explore strategic options for Taladegib through amendment of Taladegib license agreement with Lilly

March 23 (Reuters) - Ignyta Inc

* Ignyta announces exploration of strategic options for Taladegib, enabled by amendment of Taladegib license agreement with Lilly

* Ignyta - agreement amends and restates prior license, development and commercialization agreement, dated November 6, 2015, by and between Ignyta, Lilly

* Ignyta Inc - entered into amended , restated license, development, commercialization agreement with Eli Lilly and company for Taladegib Oncology program Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below